Effient
Drug
Lilly USA, LLC
Total Payments
$50,321
Transactions
680
Doctors
542
Companies
4
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $21.34 | 1 | 1 |
| 2019 | $40.12 | 2 | 2 |
| 2018 | $25.00 | 2 | 2 |
| 2017 | $50,235 | 675 | 537 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $39,847 | 4 | 79.2% |
| Food and Beverage | $10,360 | 675 | 20.6% |
| Consulting Fee | $114.70 | 1 | 0.2% |
Payments by Type
Research
$39,847
4 transactions
General
$10,475
676 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| THE TRANSLATE ACS STUDY - TREATMENT WITH ADP RECEPTOR INHIBITORS - LONGITUDINAL ASSESSMENT OF TREATMENT PATTERNS AND EVENTS AFTER ACUTE CORONARY SYNDROME | Lilly USA, LLC | $34,847 | 0 |
| A PHASE 3 DOUBLE BLIND RANDOMIZED EFFICACY AND SAFETY COMPARISON OF PRASUGREL AND PLACEBO IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE | Eli Lilly and Company | $5,000 | 0 |
Top Doctors Receiving Payments for Effient — Page 5
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Cardiovascular Disease | Torrington, CT | $23.84 | 1 |
| , MD | Interventional Cardiology | Bannockburn, IL | $23.69 | 1 |
| , D.O., F.A.C.C | Cardiovascular Disease | Wichita, KS | $23.48 | 2 |
| , MD | Cardiovascular Disease | Abingdon, VA | $23.24 | 2 |
| , MD | Cardiovascular Disease | Johnson City, TN | $23.24 | 2 |
| , M.D | Cardiovascular Disease | Canton, OH | $23.20 | 2 |
| , D.O | Cardiovascular Disease | Charleston, SC | $22.85 | 1 |
| , DO | Family Medicine | Wexford, PA | $22.80 | 1 |
| , M.D | Cardiovascular Disease | Wallingford, CT | $22.73 | 1 |
| , M.D | Interventional Cardiology | Bridgeton, MO | $22.73 | 1 |
| , MD | Cardiovascular Disease | Great Neck, NY | $22.64 | 1 |
| , MD | Cardiovascular Disease | Washington, DC | $22.56 | 1 |
| , M.D | Internal Medicine | Dallas, TX | $22.55 | 1 |
| , MD | Cardiovascular Disease | Kissimmee, FL | $22.50 | 1 |
| , MD | Internal Medicine | Oklahoma City, OK | $22.43 | 1 |
| , M.D | Cardiovascular Disease | Elkhart, IN | $22.43 | 2 |
| , MD | Cardiovascular Disease | Glendale, CA | $22.38 | 2 |
| , MD | Cardiovascular Disease | Paoli, PA | $22.25 | 1 |
| , MD | Cardiovascular Disease | Malvern, PA | $22.25 | 1 |
| , MD | Cardiovascular Disease | Paoli, PA | $22.25 | 1 |
| , M.D., M.P.H | Interventional Cardiology | Sn Bernrdno, CA | $22.13 | 1 |
| , M.D | Interventional Cardiology | San Bernardino, CA | $22.13 | 1 |
| , MD | Cardiovascular Disease | Louisville, KY | $22.07 | 1 |
| , MD | Cardiovascular Disease | Manhasset, NY | $21.90 | 1 |
| , M.D | Cardiovascular Disease | Beloit, WI | $21.63 | 2 |
Ad
Manufacturing Companies
- Lilly USA, LLC $34,847
- Daiichi Sankyo Inc. $10,360
- Eli Lilly and Company $5,000
- Daiichi Sankyo Company LTD $114.70
Product Information
- Type Drug
- Total Payments $50,321
- Total Doctors 542
- Transactions 680
About Effient
Effient is a drug associated with $50,321 in payments to 542 healthcare providers, recorded across 680 transactions in the CMS Open Payments database. The primary manufacturer is Lilly USA, LLC.
Payment data is available from 2017 to 2020. In 2020, $21.34 was paid across 1 transactions to 1 doctors.
The most common payment nature for Effient is "Unspecified" ($39,847, 79.2% of total).
Effient is associated with 2 research studies, including "THE TRANSLATE ACS STUDY - TREATMENT WITH ADP RECEPTOR INHIBITORS - LONGITUDINAL ASSESSMENT OF TREATMENT PATTERNS AND EVENTS AFTER ACUTE CORONARY SYNDROME" ($34,847).